Blood tests to improve early detection of pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study uses blood tests to look at how your immune system responds, to help find pancreatic cancer earlier. It compares people with pancreatic cancer, people with benign pancreatic conditions, and healthy people to improve diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be newly diagnosed with pancreatic cancer, have a benign pancreatic condition, or be a healthy volunteer
- You cannot have had any other type of cancer before
- Your major organs (heart, kidneys, liver) must be working normally
- You must not have a weakened immune system from conditions like HIV, active tuberculosis, or similar
- You cannot have had an organ or bone marrow transplant that requires immune-suppressing drugs
- You must be willing to come back for follow-up visits as required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special blood test to look for tiny amounts of cancer DNA after your pancreatic cancer surgery. It may help doctors see early if the cancer is coming back, so they can act sooner.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.